Try our corporate solution for free!

Annual cost of MS drugs by select countries 2013-2014

Multiple sclerosis drug annual cost in selected countries in 2013/2014

Exclusive Premium statistic

You need a Statista Account for unlimited access.

  • Full access to 1m statistics
  • Incl. source references
  • Available to download in PNG, PDF, XLS format
Statista Accounts

Access to this and all other statistics on 80,000 topics from

$468 / Year
$708 / Year

Download
Show detailed source information?
Register for free
Already a member?
Log in
Sources

Use Ask Statista Research Service

Release date

April 2015

Region

Worldwide, United States

Survey time period

2013 and 2014

Supplementary notes

MS: multiple sclerosis
Further sources: Pharmaceutical Benefits Scheme (Australia), Ontario Ministry of Health and Long-Term Care (Canada), British National Formulary (UK).
* Interfereon-ß-1b is marketed as Betaseron (Bayer) and Extavia (Novartis).
** Natalizumab was withdrawn from the market in February 2005 to evaluate progressive multifocal leukoencephalopathy risk and was reintroduced in June 2006.
*** Price pending in Canada.

Open this statistic in...
Statista Accounts: Access All Statistics. Starting from $468 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account.

Starter Account
The ideal entry-level account for individual users
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references
$59 $39 / Month *
in the first 12 months
Corporate Account
Full access

Corporate solution including all features.

* Prices do not include sales tax.

Statistics on " Drug prices in the U.S. "

Statistics on Drug prices in the U.S.

Market overview

7

United States vs. abroad

7

Price increase

8

Biosimilars' effects

5

Consumers' views

6

Further related statistics

19
Statista Accounts: Access All Statistics. Starting from $468 / Year
Learn more about how Statista can support your business.